These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38388517)

  • 1. First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [
    Hofman MS; Tran B; Feldman DR; Pokorska-Bocci A; Pichereau S; Wessen J; Haskali MB; Sparks RB; Vlasyuk O; Galetic I
    J Nucl Med; 2024 Feb; 65(5):740-3. PubMed ID: 38388517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Characterization of DPI-4452: A
    Massière F; Wiedemann N; Borrego I; Hoehne A; Osterkamp F; Paschke M; Zboralski D; Schumann A; Bredenbeck A; Brichory F; Attinger A
    J Nucl Med; 2024 May; 65(5):761-767. PubMed ID: 38514083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [
    Thomson A; Castillo C; Graefen H; Perera S; Lawrentschuk N; Perera M; Eapen R; Murphy DG
    Eur Urol; 2024 Sep; 86(3):284-285. PubMed ID: 38631995
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.
    Zhu W; Li X; Zheng G; Bai C; Ji Z; Zhang H; Xing H; Zhang Y; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3116-3125. PubMed ID: 37246998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of [
    Zhu W; Zheng G; Yan X; Liu M; Li X; Cheng Y; Bai C; Zhang Y; Huo L
    Eur J Nucl Med Mol Imaging; 2024 Nov; 51(13):4127-4133. PubMed ID: 38916753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.
    Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
    PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inferior performance of [
    Has Simsek D; Guzel Y; Denizmen D; Sanli Y; Buyukkaya F; Kovan B; Komek H; Isik EG; Ozkan ZG; Kuyumcu S
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):828-840. PubMed ID: 37947850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of
    Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
    J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of
    Gruber L; Jiménez-Franco LD; Decristoforo C; Uprimny C; Glatting G; Hohenberger P; Schoenberg SO; Reindl W; Orlandi F; Mariani M; Jaschke W; Virgolini I
    J Nucl Med; 2020 Dec; 61(12):1749-1755. PubMed ID: 32332143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
    Turkbey B; Lindenberg ML; Adler S; Kurdziel KA; McKinney YL; Weaver J; Vocke CD; Anver M; Bratslavsky G; Eclarinal P; Kwarteng G; Lin FI; Yaqub-Ogun N; Merino MJ; Linehan WM; Choyke PL; Metwalli AR
    Abdom Radiol (NY); 2016 Jan; 41(1):109-18. PubMed ID: 26830617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
    Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
    J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo.
    Krall N; Pretto F; Mattarella M; Müller C; Neri D
    J Nucl Med; 2016 Jun; 57(6):943-9. PubMed ID: 26912427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
    Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
    Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y
    Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
    Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang J; Lin Z; Zhang X; Lin R; Cui M; Miao W; Yao S
    Front Bioeng Biotechnol; 2021; 9():811972. PubMed ID: 35155411
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety, Biodistribution, and Radiation Dosimetry of
    Nicolas GP; Beykan S; Bouterfa H; Kaufmann J; Bauman A; Lassmann M; Reubi JC; Rivier JEF; Maecke HR; Fani M; Wild D
    J Nucl Med; 2018 Jun; 59(6):909-914. PubMed ID: 29025985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.